このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

The Impact of Multimodal Brain Monitoring on Postoperative Outcomes in Elderly Patients Undergoing Major Abdominal Surgery

2026年7月15日 更新者:Xuanwu Hospital, Beijing

Impact of Multimodal Brain Monitoring Under General Anesthesia on Postoperative Outcomes in Elderly Patients Undergoing Major Abdominal Surgery: A Multicenter, Prospective, Single-blind, Randomized Controlled Study

The purpose of this clinical trial is to investigate the effect of multimodal brain monitoring under general anesthesia on postoperative outcomes in elderly patients undergoing abdominal surgery.The research hypothesis is that multimodal brain monitoring under general anesthesia can reduce the incidence of postoperative composite complications and improve postoperative outcomes in elderly patients undergoing major abdominal surgery.

Eligible patients will be randomly assigned in a 1:1 ratio to the Multimodal Brain Monitoring under General Anesthesia Group (MBMGA group) and the Bispectral Index Monitoring under General Anesthesia Group (BIS group). The primary outcome is the postoperative composite complication rate . Secondary outcomes include intraoperative hyperglycemia, adverse events during anesthesia induction and maintanance, changes in blood pressure and heart rate, intraoperative hypotension, the dosage of perioperative anesthetics and vasoactive drugs, changes in serum cortisol, cardiac troponin I, blood creatinine (Cr) level, extubation time and awake time, the rate of transferring to ICU or AICU, The time to first use analgesia pump and the cumulative dose of postoperative oxycodone, systemic complications, hospitalization time, first exhaust time , first oral intake time, rate of second surgery and mortality within 30 days postoperatively.

Participants will:

  1. Undergo routine preoperative fasting for 6-8 hours;
  2. Prior to anesthesia induction, cooperate with the establishment of intravenous access, arterial catheterization, monitoring of physiological parameters, blood sample collection, and receive fluid preloading;
  3. During surgery, for patients in the MBMGA group , propofol and remifentanyl will be adjusted according to multimodal brain monitoring indices (WLi and PTi), while for patients in the BIS group, only propofol will be adjusted based on bispectral index and remifentanyl will be adjusted according to anesthesiologists' experience; simultaneously, vital signs, including respiration, body temperature, fluid therapy, blood pressure, and heart rate regulation, will be monitored and managed.
  4. After surgery, endotracheal tubes will be removed once extubation criteria are met, and patients will be transferred to the PACU, where they will receive routine monitoring and will be discharged from the PACU upon meeting corresponding scoring criteria;
  5. Participates in follow-ups on the day of surgery and for 1-30 days postoperatively, during which investigators will record the primary outcome and secondary outcomes.

調査の概要

研究の種類

介入

入学 (推定)

368

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

  • 名前:Wei Xiao, Doctor
  • 電話番号:008613810971299
  • メール:kitten15@126.com

研究場所

    • Beijing Municipality
      • Beijing、Beijing Municipality、中国
        • Peking University International Hospital
        • コンタクト:
        • 主任研究者:
          • Lan Yao
      • Beijing、Beijing Municipality、中国、10053
        • Xuanwu Hospital Capital Medical University
        • コンタクト:
        • 主任研究者:
          • Tianlong Wang
        • 副調査官:
          • Wei Xiao
    • Henan
      • Zhengzhou、Henan、中国
        • The First Affiliated Hospital of Zhengzhou University
        • 主任研究者:
          • Jianjun Yang
        • コンタクト:
    • Hubei
      • Wuhan、Hubei、中国
        • Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology
        • コンタクト:
        • 主任研究者:
          • Ailin Luo

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 高齢者

健康ボランティアの受け入れ

いいえ

説明

Inclusion Criteria:

Aged ≥65 years, regardless of gender; Scheduled for elective abdominal surgery with general anesthesia duration (from anesthesia induction to surgery completion) ≥ 2 hours; American Society of Anesthesiologists (ASA) physical status classification of I-III; Body mass index (BMI) of 18.5-29.9 kg/m²; Postoperative hospital stay expected to exceed 72 hours; Compliant with ethical standards, with voluntary signed informed consent.

Exclusion Criteria:

Severe cardiovascular diseases, including:

History of myocardial infarction within the past 6 months; Bradycardia (resting heart rate <50 beats/min); Uncontrolled hypertension (sitting systolic blood pressure ≥160 mmHg and/or diastolic blood pressure ≥100 mmHg during screening); Sitting systolic blood pressure ≤90 mmHg during screening; History of severe valvular heart disease; Uncontrolled severe respiratory infections: e.g., severe pneumonia, acute bronchitis.

Abnormal liver function: Aspartate Aminotransferase (AST) and/or Alanine Aminotransferase (ALT) ≥2.5×Upper Limit of Normal (ULN), Total Bilirubin (TBIL) ≥1.5×Upper Limit of Normal (ULN); Abnormal renal function: urea or blood urea nitrogen (BUN) ≥1.5×Upper Limit of Normal (ULN), serum creatinine >Upper Limit of Normal (ULN); Admission hemoglobin A1c (HbA1c) ≥6.5% or ≥2 fasting blood glucose measurements ≥180 mg/dl (10 mmol/L) and/or random blood glucose ≥200 mg/dL (≈11.1 mmol/L); Preoperative anemia (Hemoglobin [Hb] ≤90 g/L), thrombocytopenia (Platelet [PLT] ≤80×10⁹/L), hypoproteinemia (Albumin [Alb] ≤30 g/L); History of drug abuse and/or alcoholism within the past 2 years (alcoholism defined as daily average alcohol consumption >2 units, where 1 unit = 360 mL beer or 45 mL 40% ethanol liquor or 150 mL wine); Neurological diseases (e.g., stroke within 6 months, Alzheimer's disease, Parkinson's disease, mental disease, myasthenia gravis) or psychiatric disorders (e.g., schizophrenia, mania, bipolar disorder, delirium), history of long-term use of neuropsychiatric medications, or cognitive impairment; Allergy or contraindication to study medications; Patients refusing or unable to cooperate with the study; Scheduled for pancreatic surgery; Other conditions deemed inappropriate for participation by the investigator.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:防止
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:ダブル

武器と介入

参加者グループ / アーム
介入・治療
実験的:Multimodal Brain Monitoring Guided Anesthesia Group(MBMGA Group)
The dosage of propofol is adjusted to maintain WLi in the range of 40-70. While the dosage of remifentanil is adjusted to maintain PTi in the range of 40-70. When intraoperative pain stimulation suddenly increases ( PTi > 70 ) and lead to increased heart rate and elevated blood pressure, remifentanil 0.5-1 μg / kg will be intravenously injected and observed for 1 min. If PTi still is > 70, remifentanil 0.5-1 μg / kg will be added again until PTi reached 40-70.
During the anesthesia induction phase, the dosage administration is guided by the goal of reducing PTi to the range of 40-70, and tracheal intubation is performed when both PTi and WLI are within 40-70. In the anesthesia maintenance phase, the propofol dosage is adjusted according to the WLI value to maintain WLI within 40-70, while the remifentanil dosage is adjusted based on the PTi value to keep PTi within 40-70. In the event of sudden increased intraoperative pain stimulation (PTi > 70) accompanied by tachycardia and hypertension, an intravenous bolus of remifentanil at 0.5-1 μg/kg is administered; after 1 minute of observation, if PTi remains > 70, an additional 0.5-1 μg/kg of remifentanil is given until PTi is brought back to the 40-70 range.
アクティブコンパレータ:Bispectral Index (BIS) Monitoring Guided Anesthesia Group( BIS Group)
The dosage of propofol is adjusted according to the value of BIS, and the BIS is maintained in the range of 40 ~ 60. The dosage of remifentanil is adjusted according to the experience of anesthesiologists. The intraoperative remifentanil dosage will be maintained between 0.1 μg/kg/min and 0.3μg/kg/min.When it is highly suspected that the sudden increase of pain stimulation during operation leads to the increase of heart rate and blood pressure, remifentanil 0.5 ~ 1 μg / kg will be given intravenously for 1 min. If the heart rate and blood pressure level don't improve, remifentanil 0.5 ~ 1 μg / kg is added again until the heart rate and blood pressure have a downward trend and return to the level before the increase.
During the anesthesia induction phase, the dosage administration is guided by the goal of reducing BIS to the range of 40-60, with remifentanil supplemented based on clinical experience. In the anesthesia maintenance phase, the propofol dosage is adjusted according to BIS values to maintain BIS within 40-60, while the remifentanil dosage is adjusted based on anesthesiologists' experience. When there is a high suspicion of sudden tachycardia and hypertension induced by increased intraoperative pain stimulation, an intravenous bolus of remifentanil at 0.5-1 μg/kg is administered; after 1 minute of observation, if heart rate and blood pressure show no improvement, an additional 0.5-1 μg/kg of remifentanil is given until there is a downward trend in heart rate and blood pressure and they return to pre-stimulation levels.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Incidence of Postoperative Composite Complication
時間枠:From post-extubation to postoperative Day 30
The incidence of ≥ 1 complication occurred from the extubation to the 30 th day postoperatively The definition of postoperative composite complications refers to the rate of occurrence of one or more complications from the time of anesthesia extubation to postoperative day 7 (or the day of discharge) and within 30 days after surgery. Postoperative complications are defined as adverse events of Clavien Dindo grade II or higher occurring in any system from postoperative day 1 to day 7 (or the day of discharge) and within 30 days after surgery.
From post-extubation to postoperative Day 30

二次結果の測定

結果測定
メジャーの説明
時間枠
Incidence of intraoperative stress-induced hyperglycemia
時間枠:From anesthesia induction to skin closure, assessed up to 5 minutes after surgery

Intraoperative stress hyperglycemia is defined as:

A condition diagnosed when a patient meeting all the following criteria:

Preoperative glycemic status:

Two or more fasting blood glucose measurements < 126 mg/dL (≈7.0 mmol/L) or Random blood glucose < 200 mg/dL (≈11.1 mmol/L) during hospitalization, With concurrent HbA1c < 6.5%;

Intraoperative finding:

Highest blood glucose level ≥ 140 mg/dL (≈7.8 mmol/L) when measured at:

1 hour after intubation and/or Upon completion of surgery.

From anesthesia induction to skin closure, assessed up to 5 minutes after surgery
Incidence of intraoperative composite adverse events
時間枠:during operation, assessed up to 5 minutes after surgery

Observe and record the incidence of intraoperative composite adverse events .

Adverse events include but are not limited to:

  1. Cardiovascular Complications:

    • Hypotension

      • Hypertension

        • Severe Arrhythmia ④Acute Myocardial Ischemia

          • Acute Myocardial Infarction ⑥Acute Pulmonary Embolism

            • Acute Heart Failure ⑧Deep Vein Thrombosis
  2. Respiratory Complications:

    • Pneumonia

      • Acute Respiratory Distress Syndrome (ARDS)

        • Pulmonary Edema ④Respiratory Failure ⑤Bronchospasm

          ⑥Atelectasis

          ⑦Pleural Effusion

  3. Neurological Complications:

    ①Intraoperative Awareness

    ②Acute Stroke

  4. Renal Complications:

    • Acute Kidney Injury (AKI) ②Acute Renal Failure (ARF)
during operation, assessed up to 5 minutes after surgery
Blood pressure change immediately after intubation
時間枠:at anesthesia induction and immediately after intubation, assessed up to 10 seconds after intubation
Record blood pressure before induction and immediately after completion of intubation, and calculate the magnitude of change.
at anesthesia induction and immediately after intubation, assessed up to 10 seconds after intubation
Duration of intraoperative hypotension
時間枠:From the anesthesia induction to the end of surgery, assesed up to 5 minutes after surgery

Parameters to be recorded:

Duration of intraoperative hypotension;

Hypotension is defined as:

Mean arterial pressure < 65 mmHg or decrease of mean arterial pressure > 20% from preoperative baseline value.

From the anesthesia induction to the end of surgery, assesed up to 5 minutes after surgery
Total pintraoperative anesthetic/vasoactive drug dosages
時間枠:from the anesthesia induction to the end of surgery, assessed up to 5 minutes after surgery

Record the dosages of all medications administered during the intraoperative period, including but not limited to:

General anesthetics: Propofol, Remifentanil, Sufentanil, Oxycodone

Vasoactive agents:

  • Norepinephrine
  • Esmolol
  • Urapidil
  • Atropine
  • Ephedrine
  • Phenylephrine
from the anesthesia induction to the end of surgery, assessed up to 5 minutes after surgery
Serum cortisol levels before surgery and 24 hours postoperatively
時間枠:From before surgery and 24 hours post-operation

Measure serum cortisol concentrations at the following time points:

Preoperatively and 24 hours postoperatively

From before surgery and 24 hours post-operation
Durations from drug cessation to awake/extubation
時間枠:From drug cessation to awake/extubation , assessed up to 2 hours after entering post-anesthsia care unit
Duration from anesthesia discontinuation to awake and duration from anesthesia discontinuation to extubation
From drug cessation to awake/extubation , assessed up to 2 hours after entering post-anesthsia care unit
Rate of postoperative Intensive Care Unit/Anesthesia Intensive Care Unit transfer
時間枠:From the end of surgery to Discharge, assessed up to 2 weeks after surgery
The ratio of postoperative patients requiring transfer to either the Anesthesia Intensive Care Unit or Intensive Care Unit for any clinical indication, to the total number of surgical patients during the same period.
From the end of surgery to Discharge, assessed up to 2 weeks after surgery
Duration to first patient controlled intravenous analgesia pump use
時間枠:From the initiation of patient controlled intravenous analgesia pump use to the discontinuation of analgesic pump use, assessed up to 3 days after surgery
The duration from the end of surgery until the first activation of the patient controlled intravenous analgesia pump
From the initiation of patient controlled intravenous analgesia pump use to the discontinuation of analgesic pump use, assessed up to 3 days after surgery
Incidence of complications in other organ systems during the follow-up period except stress induced hyperglycemia
時間枠:From the start of surgery to 30 days post-operation

Follow-up assessments will be performed by a single blinded and certified anesthesia practitioner at postoperative days 1-7 and day 30, with documentation of complications involving:

Cardiovascular system; Respiratory system; Digestive system; Nervous system; Urinary system; Infection-related complications,such as wound infection Postoperative complications are defined as adverse events of Clavien Dindo grade II or higher occurring in any system from postoperative day 1 to day 7 (or the day of discharge) and within 30 days after surgery.

From the start of surgery to 30 days post-operation
Length of hospital stay
時間枠:From patient admission to discharge, assessed up to 2 weeks after surgery
the duration of patient stay in hospital
From patient admission to discharge, assessed up to 2 weeks after surgery
Rate of second operation
時間枠:From immediately after surgery to 30 days postoperatively
Observation and record the rate of secondary surgeries
From immediately after surgery to 30 days postoperatively
Mortality within 30-day postoperatively
時間枠:From immediately after surgery to 30 days postoperatively
Record the mortality within 30 days postoperatively.
From immediately after surgery to 30 days postoperatively
Incidence of acute myocardial injury
時間枠:From anesthesia induction to 24 hours after surgery
Measure blood cardiac troponin I level at the following time points: Preoperatively and 24 hours postoperatively, measurement of cardiac troponin I exceeds the 99th percentile upper reference limit
From anesthesia induction to 24 hours after surgery
Incidence of acute kidney injury
時間枠:From anesthesia induction to 24 hours after surgery

Measure blood creatinine level at the following time points:

1 day before surgery, and 24 hours postoperatively;Acute kidney injury was defined according to the KDIGO criteria as the presence of any of the following: (1) an increase in serum creatinine by ≥26.5 μmol/L (0.3 mg/dL) within 48 hours; (2) an increase in serum creatinine to ≥1.5 times baseline within the previous 7 days; or (3) a urine volume <0.5 mL/kg/h for 6 consecutive hours.

From anesthesia induction to 24 hours after surgery
Incidence of postoperative surgical site infection
時間枠:From immediately after surgery to 30 days postoperatively
surgical site infection refers to the proportion of surgical cases with surgical site infection (SSI) occurring from after surgery to before discharge, relative to the total number of surgical procedures performed on hospitalized patients during the same period. Postoperative wound infection is defined as an infection related to the surgical procedure and occurring near the surgical site within 30 days after surgery. Postoperative wound infections include: superficial incisional SSI, deep incisional SSI, and organ/space SSI.
From immediately after surgery to 30 days postoperatively
Heart rate change immediately after intubation
時間枠:at anesthesia induction and immediately after intubation, assessed up to 10 seconds after intubation
Record heart rate before induction and immediately after completion of intubation, and calculate the magnitude of change.
at anesthesia induction and immediately after intubation, assessed up to 10 seconds after intubation
Duration to postoperative first flatus time
時間枠:From the end of surgery to 7 days after surgery
Duration to postoperative first flatus time
From the end of surgery to 7 days after surgery
Duration to postoperative first oral intake
時間枠:From the end of surgery to 7 days after surgery
Duration to postoperative first oral intake
From the end of surgery to 7 days after surgery
Minimum intraoperative mean arterial pressure
時間枠:From the anesthesia induction to the end of surgery, assesed up to 5 minutes after surgery

Parameters to be recorded:

Minimum intraoperative mean arterial pressure ;

From the anesthesia induction to the end of surgery, assesed up to 5 minutes after surgery
Incidence of hypotension.
時間枠:From the anesthesia induction to the end of surgery, assesed up to 5 minutes after surgery

Parameters to be recorded:

Incidence of hypotension;

Hypotension is defined as:

Mean arterial pressure < 65 mmHg or decrease of mean arterial pressure > 20% from preoperative baseline value.

From the anesthesia induction to the end of surgery, assesed up to 5 minutes after surgery
Durations of post-anesthesia care unit stay
時間枠:From entering post-anesthesia care unit to post-anesthesia care unit discharge, assessed up to 2 hours after entering post-anesthsia care unit
Duration of post-anesthesia care unit stay
From entering post-anesthesia care unit to post-anesthesia care unit discharge, assessed up to 2 hours after entering post-anesthsia care unit
Cumulative postoperative oxycodone dosage
時間枠:From the initiation of patient controlled intravenous analgesia pump use to the discontinuation of analgesic pump use, assessed up to 3 days after surgery
Cumulative postoperative oxycodone dose
From the initiation of patient controlled intravenous analgesia pump use to the discontinuation of analgesic pump use, assessed up to 3 days after surgery
The duration of intraoperative deep sedation
時間枠:from anesthesia induction to the end of surgery, assessed up to 5 minutes after surgery
The duration of intraoperative wavelet index below 40 or Bispectral Index below 40
from anesthesia induction to the end of surgery, assessed up to 5 minutes after surgery
The duration of intraoperative inadequate analgesia
時間枠:from anesthesia induction to the end of surgery, assessed up to 5 minutes after surgery
The duration of intraoperative pain threshold index higher than 70
from anesthesia induction to the end of surgery, assessed up to 5 minutes after surgery
Scores of Intake, Feeling nauseated, Emesis, physical Exam, and Duration of symptoms at 72 hours after surgery
時間枠:at 72 hours after surgery
Scores of Intake, Feeling nauseated, Emesis, physical Exam, and Duration of symptoms at 72 hours after surgery, Intake, Feeling nauseated, Emesis, physical Exam, and Duration of symptoms is a scoring system to evaluate the postoperative gastrointestinal function, if the score is higher than 6, it indicating gastrointestinal dysfunction.
at 72 hours after surgery

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Tianlong Wang, Doctor、Xuanwu Hospital, Beijing

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年8月1日

一次修了 (推定)

2028年5月30日

研究の完了 (推定)

2028年12月30日

試験登録日

最初に提出

2026年7月13日

QC基準を満たした最初の提出物

2026年7月15日

最初の投稿 (実際)

2026年7月20日

学習記録の更新

投稿された最後の更新 (実際)

2026年7月20日

QC基準を満たした最後の更新が送信されました

2026年7月15日

最終確認日

2026年7月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • Linyanshen[2025]075-004-xz-1

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

はい

IPD 共有時間枠

One year after results publicated

IPD 共有アクセス基準

Contacting the corresponsible author.

IPD 共有サポート情報タイプ

  • STUDY_PROTOCOL

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する